Precision oncology for KRAS^G12C-mutant colorectal cancer

Nat Rev Clin Oncol. 2023 Jun;20(6):355-356. doi: 10.1038/s41571-023-00748-z.

Authors

Federica Di Nicolantonio^{1

2}, Alberto Bardelli^{3

4}

Affiliations

¹ Department of Oncology, University of Torino, Candiolo, Turin, Italy. federica.dinicolantonio@unito.it.
² Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. federica.dinicolantonio@unito.it.
³ Department of Oncology, University of Torino, Candiolo, Turin, Italy. alberto.bardelli@unito.it.
⁴ IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy. alberto.bardelli@unito.it.

PMID: 36914743
DOI: 10.1038/s41571-023-00748-z

No abstract available

Publication types

Comment

MeSH terms

Colorectal Neoplasms*
Humans
Lung Neoplasms*
Mutation
Precision Medicine
Proto-Oncogene Proteins p21(ras)
Signal Transduction

Substances

Proto-Oncogene Proteins p21(ras)
KRAS protein, human